DAFNA Capital Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

DAFNA Capital Management’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-120,097	Closed	-$137K	–	95
2022 Q1	$137K	Sell	120,097 -116,063	-49%	-$139K	0.04%	93
2021 Q4	$531K	Hold	236,160	–	–	0.13%	78
2021 Q3	$808K	Sell	236,160 -223,100	-49%	-$688K	0.21%	71
2021 Q2	$1.37M	Hold	459,260	–	–	0.29%	67
2021 Q1	$1.48M	Buy	+459,260	New	+$1.53M	0.35%	65

Other funds holding INFI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

DAFNA Capital Management's INFI Position: Q2 2022 in Review

DAFNA Capital Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2022, closing a stake of 120,097 shares — an estimated $137K sold.

DAFNA Capital Management first reported a position in INFI in Q1 2021 and held it in 5 quarters. The position peaked at $1.48M in Q1 2021. 77 funds tracked by Wall St. Rank hold INFI as of Q2 2022.

DAFNA Capital Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
DAFNA Capital Management sold 120,097 Infinity Pharmaceuticals, Inc. shares in Q2 2022, an estimated $137K.
DAFNA Capital Management first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2021 and held it in 5 quarters.
DAFNA Capital Management's Infinity Pharmaceuticals, Inc. position peaked at $1.48M in Q1 2021.
77 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2022.

Based on DAFNA Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.